Drug Markets/Finerenone

Finerenone

9 NDCs across 1 manufacturer|0 Generic,9 Brand

▸ More about this market

The brand product was first FDA-approved on Jul 9, 2021. In 2024, Medicare Part D spent $396 million on Finerenone across 404,000 claims for 88,000 beneficiaries.

Finerenone is available as 9 NDCs from 1 manufacturer (0 generic, 9 brand), with NADAC prices from $22.85 to $22.86 per EA — a 0% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

9

0G / 9B

Manufacturers

1

competing in market

Price Spread

$22.85 – $22.86

per EA

7d Activity

6↑3↓0 flat

avg -0.0% WoW · of 9 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing FINERENONE

Drug Portfolio

9 NDCs total, 9 shown

Frequently Asked Questions

How much does Medicare spend on Finerenone?

In 2024, Medicare Part D spent $396 million on Finerenone across 404,000 claims for 88,000 beneficiaries.

How many Finerenone products are on the market?

The Finerenone drug market contains 9 NDCs from 1 manufacturer — 0 generic and 9 brand products.

What is the price range for Finerenone?

NADAC reference prices for Finerenone range from $22.8515 to $22.8643 per EA — a 0% difference between cheapest and most expensive.

Which manufacturers make Finerenone?

1 manufacturer lists Finerenone in NADAC. Ranked by number of NDCs, the largest are Bayer HealthCare Pharmaceuticals Inc. (9).

How has the price of Finerenone changed recently?

Over the past 7 days, 6 Finerenone NDCs rose and 3 fell, with a market-wide average change of -0.0%.